349 related articles for article (PubMed ID: 25256233)
1. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
[TBL] [Abstract][Full Text] [Related]
2. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
3. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
[TBL] [Abstract][Full Text] [Related]
4. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
Yu P; Qian AS; Chathely KM; Trigatti BL
Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
[TBL] [Abstract][Full Text] [Related]
5. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
Kayashima Y; Makhanova N; Maeda N
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
[TBL] [Abstract][Full Text] [Related]
6. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of AXL in Bone Marrow-Derived Cells Does Not Affect Advanced Atherosclerotic Lesion Progression.
Subramanian M; Proto JD; Matsushima GK; Tabas I
Sci Rep; 2016 Dec; 6():39111. PubMed ID: 27958361
[TBL] [Abstract][Full Text] [Related]
8. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis.
Ait-Oufella H; Pouresmail V; Simon T; Blanc-Brude O; Kinugawa K; Merval R; Offenstadt G; Lesèche G; Cohen PL; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1429-31. PubMed ID: 18467644
[TBL] [Abstract][Full Text] [Related]
9. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet.
Kusters DH; Chatrou ML; Willems BA; De Saint-Hubert M; Bauwens M; van der Vorst E; Bena S; Biessen EA; Perretti M; Schurgers LJ; Reutelingsperger CP
PLoS One; 2015; 10(6):e0130484. PubMed ID: 26090792
[TBL] [Abstract][Full Text] [Related]
11. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2
Wang W; Liu W; Fidler T; Wang Y; Tang Y; Woods B; Welch C; Cai B; Silvestre-Roig C; Ai D; Yang YG; Hidalgo A; Soehnlein O; Tabas I; Levine RL; Tall AR; Wang N
Circ Res; 2018 Nov; 123(11):e35-e47. PubMed ID: 30571460
[TBL] [Abstract][Full Text] [Related]
13. Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice.
Parma L; Peters HAB; Baganha F; Sluimer JC; de Vries MR; Quax PHA
Cells; 2020 Feb; 9(2):. PubMed ID: 32024075
[TBL] [Abstract][Full Text] [Related]
14. Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice.
Kiouptsi K; Pontarollo G; Todorov H; Braun J; Jäckel S; Koeck T; Bayer F; Karwot C; Karpi A; Gerber S; Jansen Y; Wild P; Ruf W; Daiber A; Van Der Vorst E; Weber C; Döring Y; Reinhardt C
Gut Microbes; 2020 Nov; 11(6):1809-1823. PubMed ID: 32579470
[TBL] [Abstract][Full Text] [Related]
15. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
16. Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility.
Medina I; Cougoule C; Drechsler M; Bermudez B; Koenen RR; Sluimer J; Wolfs I; Döring Y; Herias V; Gijbels M; Bot I; de Jager S; Weber C; Cleutjens J; van Berkel TJC; Sikkink KJ; Mócsai A; Maridonneau-Parini I; Soehnlein O; Biessen EAL
Circulation; 2015 Aug; 132(6):490-501. PubMed ID: 26068045
[TBL] [Abstract][Full Text] [Related]
17. SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
Gurzeler E; Ruotsalainen AK; Laine A; Valkama T; Kettunen S; Laakso M; Ylä-Herttuala S
PLoS One; 2021; 16(11):e0258408. PubMed ID: 34767557
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis.
Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP
Circ Res; 2009 Nov; 105(11):1141-8. PubMed ID: 19834008
[TBL] [Abstract][Full Text] [Related]
19. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.
Yancey PG; Blakemore J; Ding L; Fan D; Overton CD; Zhang Y; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):787-95. PubMed ID: 20150557
[TBL] [Abstract][Full Text] [Related]
20. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
